Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Hand Function after Distal Radial Access: Is it Safe?

The benefit of the transradial approach in percutaneous interventions is well known. Its main limitation is radial artery occlusion (RAO) which would compromise the artery for future use in percutaneous procedures. Even though it is clinically silent, reported cases might reach 33%. 

Función de la mano luego del acceso radial distal, ¿es seguro?

More recently, the distal radial access (DRA) has surged as an alternative to reduce RAO. However, its safety and potential to produce negative effects in hand function have not been studied yet. 

The aim of this prospective, multicenter, cohort study was to assess hand function at long term in patients treated with DRA for coronary procedures. 

Multiple outcomes were presented to assess hand dysfunction, including coordination questionnaires, dexterity, strength, and sensation tests up to 12-month followup. 

The study looked at 313 patients. Mean age was 66 and they were mostly men. 22% presented prior radial access. As regards procedure characteristics, 54% of DRA was left, ultrasound was used to guide puncture in 85 % of cases, and they were mostly diagnostic procedures. DRA failed in 2.9% of cases. 

Read also: FFR and IFR: Are We Talking About the Same Thing?

DRA showed no hand function deterioration according to the questionnaires for subjective and objective assessment and was even associated to less pain and <1% RAO rate.  

Conclusion 

The distal radial access was not associated with worse hand function. On the contrary, it was associated to lower complications rate with good tolerance to the procedure. 

Dr. Andrés Rodríguez
Member of the editorial board of SOLACI.org.

Original Title: International Hand Function Study Following Distal Radial Access The RATATOUILLE Study.

Reference: Gregory A. Sgueglia, MD et al J Am Coll Cardiol Intv 2022.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SCAI 2026 | SELUTION DeNovo subanalysis: Use of sirolimus-eluting balloon in acute coronary syndrome

Percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation remains the predominant strategy in the setting of acute coronary syndrome (ACS). However, in recent...

Calcified Nodules and Their Treatment with Rotational Atherectomy

Calcified nodules (CN) represent one of the most complex phenotypes to treat in coronary intervention. They are mainly associated with the need for repeat...

Complex PCI: higher ischemic and bleeding risk in contemporary practice

Advances in pharmacological therapies, equipment, and devices have enabled percutaneous coronary interventions (PCI) to be performed in a growing number of patients with a...

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

SCAI 2026 | Deep vein arterialization as an alternative in patients with critical limb ischemia without conventional options

Critical limb ischemia (CLI) represents one of the most advanced stages of peripheral arterial disease (PAD). In a significant proportion of patients, distal anatomy,...

SCAI 2026 | Can an atrial fixation device prevent complications of transcatheter mitral valve replacement? Analysis of the AltaValve system

Transcatheter mitral valve replacement (TMVR) represents one of the most complex areas within structural interventions. Unlike TAVI, where valvular anatomy typically provides more predictable...

SCAI 2026 | SELUTION DeNovo subanalysis: Use of sirolimus-eluting balloon in acute coronary syndrome

Percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation remains the predominant strategy in the setting of acute coronary syndrome (ACS). However, in recent...